Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
archive
clinical trials
drugs
life sciences
medical
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
boston
boston blog main
boston top stories
cannabidiol
dravet syndrome
epidiolex
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
healthcare
lennox-gastaut syndrome
medicine
onpattro
patisiran
paul matteis
recalls
rna interference
san francisco
san francisco blog main
san francisco top stories
stifel financial
usa
zogenix
What
fda
weeks
5
×
drug
ago
approval
approved
expected
medicine
new
pharmaceuticals
time
administration
allows
alnylam
announcement
approves
battle
bec
cannabis
certain
coming
covering
covid
data
derivative
doctors
drugs
ebola
epilepsy
equipment
food
form
gw
gw’s
health
helps
high
highlighting
history
home
Language
unset
Current search:
weeks
×
fda
×
@slashgear.com
3 years ago
Popular thyroid drugs recalled because they’re weaker than expected
@slashgear.com
4 years ago
Temporary FDA policy helps doctors monitor COVID-19 patients at home
@slashgear.com
4 years ago
FDA approves first US Ebola vaccine: What you should know
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug